Drugs for Neglected Diseases, Takeda deal

DNDi and Takeda partnered to identify the best candidate from an aminopyrazole series of small molecules to treat visceral leishmaniasis. The Global Health Innovative Technology (GHIT) Fund (Tokyo, J...